LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada
ConditionLung Neoplasms
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-130
SponsorAstraZeneca
About this trial
LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with lung cancer between January 1, 2018 and end of the Selection Period.
Patient is 18 years of age or older on diagnosis date.
Patient has at least 12 months of health insurance coverage prior to the diagnosis date.
Disqualifiers
Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
Non-Ontario or non-Alberta resident on diagnosis date.
Trial population
Study population will comprise patients with lung cancer diagnosed after January 1, 2018 in the administrative databases for Alberta and Ontario.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
60,000 Participants
are grouped into 2 trial groupsGroup A: Non-Small Cell Lung Cancer (NSCLC)
Group B: Small Cell Lung Cancer (SCLC)
Trial outcomes
Primary outcomes
1
Treatment patterns
Time frame
Through study completion, an average of 1 yearSecondary outcomes
1
Incidence and prevalence
Time frame
Through study completion, an average of 1 year2
Baseline demographic and clinical characteristics
Time frame
Through study completion, an average of 1 year3
Overall survival
Time frame
Through study completion, an average of 6 months4
Time to/on therapy
Time frame
Through study completion, an average of 6 monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov